Werner Kroll - 27 May 2022 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Reporting relationship: SVP, Research and Development
Issuer ticker: QDEL
Reported as of: 27 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jun 2022, 17:45:37 UTC
Prior SEC filing: 14 Feb 2022
Next SEC filing: 06 Jul 2022
Source filing: View source filing
Reporting owner signature: /s/ Phillip S. Askim, attorney-in-fact for Werner Kroll

Key filing fact

Werner Kroll filed Form 4 for QuidelOrtho Corp (QDEL) on 01 Jun 2022.

Key facts

This page summarizes Werner Kroll's Form 4 filing for QuidelOrtho Corp (QDEL).
12 reported transactions and 11 derivative rows are listed below.
Accepted by SEC: 01 Jun 2022, 17:45.

Change

Previous filing in this sequence was filed on 14 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Award

Transaction value
Shares: +18,762
Change %
Price
Shares after: 18,762
Date: 27 May 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Non-Qualified Stock Options

Award

Transaction value: $0
Shares: +2,303
Change %
Price: $0.000000
Shares after: 2,303
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,303
Exercise price: $46.41
Footnotes: F2, F3

QDEL transaction Derivative

Non-Qualified Stock Options

Award

Transaction value: $0
Shares: +3,924
Change %
Price: $0.000000
Shares after: 3,924
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,924
Exercise price: $59.12
Footnotes: F2, F4

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +3,925
Change %
Price: $0.000000
Shares after: 3,925
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,925
Exercise price
Footnotes: F5, F6, F7

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +2,743
Change %
Price: $0.000000
Shares after: 2,743
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,743
Exercise price
Footnotes: F5, F6, F8

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +823
Change %
Price: $0.000000
Shares after: 823
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 823
Exercise price
Footnotes: F5, F6, F8

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +4,268
Change %
Price: $0.000000
Shares after: 4,268
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,268
Exercise price
Footnotes: F5, F6, F9

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +1,962
Change %
Price: $0.000000
Shares after: 1,962
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,962
Exercise price
Footnotes: F5, F6, F10

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +2,625
Change %
Price: $0.000000
Shares after: 2,625
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,625
Exercise price
Footnotes: F5, F6, F11

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +3,510
Change %
Price: $0.000000
Shares after: 3,510
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,510
Exercise price
Footnotes: F5, F6, F12

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +10,642
Change %
Price: $0.000000
Shares after: 10,642
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,642
Exercise price
Footnotes: F5, F6, F13

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +7,256
Change %
Price: $0.000000
Shares after: 7,256
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,256
Exercise price
Footnotes: F5, F6, F14

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 14 footnotes

Footnote F1

Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

Footnote F2

Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

Footnote F3

Vested in full.

Footnote F4

5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023.

Footnote F5

Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

Footnote F6

Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

Footnote F7

3,925 shares will vest on February 4, 2023.

Footnote F8

Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

Footnote F9

4,268 shares will vest on February 4, 2023.

Footnote F10

1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023.

Footnote F11

1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024.

Footnote F12

3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024.

Footnote F13

3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025.

Footnote F14

3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

SEC remarks

SVP, Research and Development